Although there are conflicting results about irisin levels in type II diabetes, a meta-analysis showed that irisin levels were decreased in type II diabetes and they were found to be increased in insulin resistance and metabolic syndrome (26). This evidence concerns the gene FNDC5 and type 2 diabetes mellitus.